Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome
Open Access
- 9 November 1999
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (23), 13342-13344
- https://doi.org/10.1073/pnas.96.23.13342
Abstract
Lowe syndrome is an X-linked disorder that has a complex phenotype that includes progressive renal failure and blindness. The disease is caused by mutations in an inositol polyphosphate 5-phosphatase designated OCRL. It has been shown that the OCRL protein is found on the surface of lysosomes and that a renal tubular cell line deficient in OCRL accumulated substrate phosphatidylinositol 4,5-bisphosphate. Because this lipid is required for vesicle trafficking from lysosomes, we postulate that there is a defect in lysosomal enzyme trafficking in patients with Lowe syndrome that leads to increased extracellular lysosomal enzymes and might lead to tissue damage and contribute to the pathogenesis of the disease. We have measured seven lysosomal enzymes in the plasma of 15 patients with Lowe syndrome and 15 age-matched male controls. We find a 1.6- to 2.0-fold increase in all of the enzymes measured. When the data was analyzed by quintiles of activity for all of the enzymes, we found that 95% of values in the lowest quintile come from normal subjects whereas in the highest quintile 85% of the values are from patients with Lowe syndrome. The increased enzyme levels are not attributable to renal insufficiency because there was no difference in enzyme activity in the four patients with the highest creatinine levels compared with the six patients with the lowest creatinine values.Keywords
This publication has 16 references indexed in Scilit:
- Identification of two novel mutations in the OCRLI gene in Japanese families with Lowe syndromeClinical Genetics, 2008
- Characterization of a Germline Mosaicism in Families with Lowe Syndrome, and Identification of Seven Novel Mutations in the OCRL1 GeneAmerican Journal of Human Genetics, 1999
- Coupled Inositide Phosphorylation and Phospholipase D Activation Initiates Clathrin-coat Assembly on LysosomesPublished by Elsevier BV ,1999
- Mutations Are Not Uniformly Distributed throughout theOCRL1Gene in Lowe Syndrome PatientsMolecular Genetics and Metabolism, 1998
- Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.JCI Insight, 1998
- Spectrum of Mutations in the OCRL1Gene in the Lowe Oculocerebrorenal SyndromeAmerican Journal of Human Genetics, 1997
- Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of loweAmerican Journal of Medical Genetics, 1995
- Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of LoweHuman Molecular Genetics, 1993
- The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphataseNature, 1992
- Acid hydrolases in serum from patients with lysosomal disordersClinica Chimica Acta; International Journal of Clinical Chemistry, 1980